Table 4. Comparison of results before the introduction of DTG/DRV/r therapy and at 48 weeks of treatment.
| Before the introduction of DLT/DRV/r | 48 weeks of treatment | P | |||
|---|---|---|---|---|---|
| MEDIAN (LQ- UQ) | Mean ±SD | MEDIAN (LQ- UQ) | Mean ±SD | ||
| Lymphocyte CD4+ (cells/μl) | 560.5 (362.5–756.3) |
560.7±276.6 |
641.0 (433.5–801.5) |
639.6±280.6 | <0.0001 |
| Lymphocyte CD4+/CD8+ |
0.7 (0.4–0.9) |
0.7±0.3 | 0.7 (0.5–0.9 |
0.7±0.3 | <0.0001 |
| Total cholesterol (mg/dL) | 174.8 (150.2–192.3) |
173,8±34.9 | 185.8 (161.3–200.8) |
186.5±36.1 | <0.05 |
| Cholesterol LDL (mg/dL) | 98.7 (77.6–119.9) |
97.37±29.4 | 103.7 (83.7–119.1) |
101.6±27.8 | >0.05 |
| Triglyceride (mg/dL) | 132.0 (90.0–185.1) |
159.3±97.6 | 138.1 (100.0–202.7) |
170.6±108.8 | >0.05 |